December 2014

Life sciences


Healthcare innovation: patients at the centre of the debate - Eighth annual Quebec City Healthcare Industry Forum

At the initiative of Québec International, the eighth annual Quebec City Healthcare Industry Forum (FISQ) will be held on December 2. This daylong event will bring together key stakeholders from this vitally important sector, including clinicians, professionals, healthcare system managers, industrialists, researchers and experts. The attendees will be pursuing a shared goal: to find solutions in which innovation is genuinely placed at the service of Quebecers' health.


Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) announced in August a strategic co-promotion services agreement with ASCEND Therapeutics® US, LLC.


1,000 medical imaging scientists to visit Québec City in 2017

The Medical Image Computing and Computer Assisted Intervention Society (MICCAI) has chosen Québec City as the host city for the 20th International Conference on Medical Image Computing and Computer Assisted Intervention.


Cosmétopée Project: today Québec Region and Province, tomorrow the world!

The Cosmétopée Québec database is the first practical manifestation of Projet Cosmétopée initiated by the French Cosmetic Valley. Developed here by Québec International, the database lists Québec’s main forest and marine resources .Québec International Business Development Director – Life Sciences, Jean-Michel Garro, presented the Cosmétopée Québec project at 2014 Beyond Beauty in Paris ealier this september.


Plant-based vaccines challenge big pharma for $3 billion flu market

Leading producers such as GlaxoSmithKline Plc and Sanofi SA need six months to produce flu vaccine once scientists identify the dominant virus expected to circulate during flu season. Vaccine production from tobacco plants by Quebec City-based Medicago could do it in weeks.


Opsens receive Shonin approval to market FFR products in Japan

Opsens Inc. (TSX-V: OPS) is pleased to announce that its Japanese distributor received Shonin approval from the Japanese Ministry of Health, Labor and Welfare ("MHLW") to market the OptoWire and the OptoMonitor, our products that measure Fractional Flow Reserve ("FFR") in patients with coronary artery disease.


Université Laval scientists win top award for spinal cord injury research

Two scientists from Université Laval have received the 2014 and 2013 Barbara Turnbull Award for Spinal Cord Research, an annual prize supported through a partnership between the Barbara Turnbull Foundation, Brain Canada, and the Canadian Institutes of Health Research (CIHR). Drs. Yves De Koninck (2014) and Frédéric Bretzner (2013) of Université Laval are recipients of this prestigious award for their world-class work to advance research on spinal cord injury and find new treatments.


Opsens granted CE marking for sale of FFR products in Europe

Opsens Inc. (TSXV:OPS) is pleased to announce that it has been granted CE marking for OptoWire and OptoMonitor, which allows these Fractional Flow Reserve (FFR) products for patients with coronary artery disease to be marketed in Europe, the world's second largest market.